- Home Page >
- Useful Links >
- Clinical Content Policy
Clinical Content Policy
Useful Links
Need some assistance?
Give one of our friendly team members a call on 020 3597 6817 or email us at [email protected]
Useful Links
Version 1.0
Effective Date: 08.10.2026
1. About This Policy
At Pharmulous, we are committed to providing accurate, reliable and easy-to-understand healthcare information to help our customers make informed decisions about their health and treatment options.
This Clinical Content Policy explains the standards and procedures we follow when researching, creating, reviewing, publishing and maintaining healthcare-related content on our website, www.pharmulous.co.uk.
Our aim is to ensure that the information we provide is evidence-based, clinically appropriate, transparent and accessible.
This policy applies to healthcare-related content published on our website, including information about medical conditions, treatments, medicines, product descriptions, health advice and educational articles.
2. Our Commitment to Quality and Accuracy
We aim to ensure that our clinical content meets the following principles:
- Accuracy: Information is based on reliable clinical evidence, recognised medical guidance and authoritative healthcare sources.
- Clinical Reliability: Content is reviewed by appropriately qualified healthcare professionals where clinical oversight is required.
- Clarity: Information is presented in straightforward language that is accessible and easy to understand.
- Transparency: We aim to provide balanced information about treatments, including their potential benefits, limitations, risks and side effects.
- Relevance: Content is reviewed and updated to reflect significant changes in clinical guidance, medicine safety information and relevant healthcare developments.
- Editorial Integrity: Clinical information is guided by evidence, professional judgement and patient safety rather than commercial considerations.
We recognise that healthcare information can influence important decisions, and we take our responsibility to provide trustworthy content seriously.
3. Content Creation and Research
Our healthcare content is developed using recognised clinical resources and evidence-based information.
Content may be prepared by healthcare professionals, experienced content writers or other suitably qualified contributors.
When creating content, we aim to ensure that:
- Information is researched using credible and authoritative sources.
- Medical and pharmaceutical claims are supported by appropriate evidence.
- Treatment information reflects relevant UK clinical guidance and approved medicine information.
- Important safety information, including contraindications, precautions, interactions and potential side effects, is communicated where relevant.
- Medical terminology is explained in language that is accessible to the general public.
- Content avoids misleading, exaggerated or unsupported claims.
- Information is appropriate for its intended purpose and audience.
Clinical content is subject to appropriate editorial checks and professional review where required before publication.
4. Use of Artificial Intelligence (AI)
Pharmulous recognises that artificial intelligence (AI) can support the development and improvement of healthcare content.
AI-assisted tools may be used to support certain editorial activities, including research assistance, content planning, drafting, structuring, proofreading and improving readability.
However, AI-generated information is not considered a substitute for reliable clinical evidence, professional healthcare expertise or independent clinical judgement.
Where AI tools are used in preparing clinical content, the following principles apply:
- Human Oversight: AI-assisted content is subject to appropriate human editorial oversight before publication.
- Clinical Accuracy: Clinical information is checked against reliable and authoritative healthcare sources.
- Professional Review: Content requiring clinical review is assessed by an appropriately qualified healthcare professional, such as a registered doctor or pharmacist.
- Patient Safety: AI-generated statements concerning medicines, treatment suitability, contraindications or other patient safety matters are not relied upon without appropriate verification.
- Transparency: AI is used as a supporting editorial tool rather than as an independent source of clinical authority.
- Data Protection: AI tools must be used in accordance with applicable data protection requirements, including the UK General Data Protection Regulation (UK GDPR), and relevant privacy and information governance procedures.
AI-generated content is not regarded as independently clinically verified.
Responsibility for the accuracy, suitability and approval of published healthcare information remains with the appropriate human contributors and reviewers.
Our priority is to ensure that the information available to customers remains reliable, evidence-based and clinically appropriate, regardless of the tools used during its preparation.
5. Clinical Review Process
Clinical content requiring professional oversight is reviewed by an appropriately qualified healthcare professional before publication.
Depending on the subject matter, clinical reviewers may include registered doctors, pharmacists or other suitably qualified healthcare professionals.
The clinical review process considers:
- The accuracy and reliability of the information presented.
- Consistency with current clinical evidence and relevant UK healthcare guidance.
- The accuracy of medicine information, including indications, dosages, contraindications, precautions and potential side effects.
- Whether treatment benefits, risks and limitations are presented fairly and accurately.
- Whether the information is understandable and appropriate for patients.
- Whether statements require further clarification, correction or supporting evidence.
Clinical reviewers assess content within their professional expertise and scope of practice.
Where appropriate, the name, professional title, qualifications and registration details of the reviewing healthcare professional may be displayed alongside the content.
Clinical review of website information is separate from the individual clinical assessment required when prescribing or supplying medicines.
6. Sources of Clinical Information
Pharmulous prioritises reputable and authoritative healthcare resources when developing and reviewing clinical content.
These may include, but are not limited to:
- National Health Service (NHS): Information about health conditions, symptoms, medicines and treatment options.
- National Institute for Health and Care Excellence (NICE): Evidence-based clinical guidelines and recommendations.
- Medicines and Healthcare products Regulatory Agency (MHRA): Medicine safety information, regulatory guidance and safety alerts.
- British National Formulary (BNF): Prescribing guidance and medicine information.
- Electronic Medicines Compendium (emc): Summaries of Product Characteristics and Patient Information Leaflets.
- General Medical Council (GMC): Professional standards and guidance for registered doctors.
- General Pharmaceutical Council (GPhC): Professional standards and guidance for pharmacy professionals.
- Peer-reviewed Medical Literature: Relevant scientific research, clinical studies and published evidence.
Sources are selected according to their relevance, reliability and suitability for the information being presented.
Where appropriate, references may be included within our content to support clinical statements and allow readers to explore the information further.
7. Content Review and Updates
Medical knowledge, treatment recommendations and regulatory guidance can change over time.
Pharmulous aims to maintain the accuracy and relevance of its published healthcare information through ongoing editorial oversight and content review.
Content may be reviewed or updated in response to:
- Changes to NHS, NICE or other recognised clinical guidance.
- New MHRA medicine safety alerts or regulatory announcements.
- Changes to approved medicine information, prescribing recommendations or treatment availability.
- Newly published clinical evidence that materially affects existing information.
- Identified inaccuracies, outdated information or patient safety concerns.
- Feedback from healthcare professionals, customers or other relevant sources.
Content involving significant patient safety information may be prioritised for review where urgent changes are required.
Where applicable, the date of the most recent clinical review will be displayed on the relevant webpage.
The frequency of routine reviews depends on the nature of the content, its clinical significance and the likelihood of relevant information changing.
8. Editorial Independence and Integrity
Pharmulous is committed to maintaining the integrity, accuracy and impartiality of its healthcare information.
Clinical content should be developed and reviewed with patient safety, professional judgement and evidence-based information as primary considerations.
Commercial interests must not compromise the accuracy or balance of clinical information.
Where medicines or treatment options are discussed, we aim to provide factual information about their intended use, potential benefits, limitations and relevant risks.
We do not knowingly publish misleading medical claims, unsupported treatment recommendations or information that could compromise patient safety.
Content relating to medicines and healthcare services must comply with applicable UK advertising and medicines regulations, including relevant requirements of the Advertising Standards Authority (ASA), the Committee of Advertising Practice (CAP) and the MHRA.
9. Clinical Reviewers and Professional Credentials
Clinical reviewers are selected according to their qualifications, professional experience and expertise in the relevant subject matter.
Where appropriate, reviewers may include:
Registered Doctors
Doctors may review information relating to medical conditions, clinical assessment, treatment options, prescribing considerations and other areas within their professional competence.
Registered Pharmacists
Pharmacists may review information relating to medicines, pharmaceutical care, dosage, interactions, contraindications, side effects and safe medicine use.
Other Qualified Healthcare Professionals
Other appropriately qualified healthcare professionals may review content relevant to their professional expertise and scope of practice.
Where reviewer details are published, these may include their name, professional title, qualifications and relevant professional registration number.
Professional registrations may be verified through the appropriate regulatory body, including the GMC or GPhC.
10. Corrections and Content Accuracy
We recognise the importance of identifying and correcting inaccurate, unclear or outdated healthcare information.
Where a potential error is brought to our attention, we aim to assess the concern and make appropriate corrections where necessary.
Corrections involving clinical accuracy, medicine safety or treatment recommendations may be referred to a suitably qualified healthcare professional for review.
Where information could present a significant risk to patient safety, corrective action will be prioritised.
We welcome feedback from customers, healthcare professionals and readers who identify information that may require clarification, correction or updating.
11. Medical Information Disclaimer
The healthcare information provided on the Pharmulous website is intended for general educational and informational purposes.
Although we take reasonable steps to ensure that our content is accurate and reliable, it should not be considered a substitute for personalised medical advice, diagnosis or treatment from an appropriately qualified healthcare professional.
Information published on our website does not establish that a particular medicine or treatment is suitable for an individual patient.
Prescription-only medicines are supplied only following an appropriate clinical assessment and approval by an authorised prescriber, in accordance with applicable professional and regulatory requirements.
Customers should seek advice from an appropriate healthcare professional if they have questions about their health, medicines or treatment options.
For urgent medical concerns, seek assistance through the appropriate NHS service. In a life-threatening emergency, call 999.
12. Feedback and Contact Information
We welcome feedback regarding the accuracy, quality and clarity of the healthcare information published on our website.
If you believe any of our content is inaccurate, outdated, misleading or requires clarification, please contact us by email at:
Email: [email protected]
We take feedback relating to clinical content seriously and aim to review any concerns raised, making corrections or updates where appropriate.
13. Changes to This Policy
Pharmulous may review and update this Clinical Content Policy from time to time to reflect changes in our editorial procedures, clinical standards, regulatory requirements or website operations.
Any updates will be published on this page, together with a revised version number and effective date where appropriate.
We encourage visitors to review this policy periodically for information about how our healthcare content is created and maintained.
Sign up to our newsletter
Sign up to be the first to know about promotions and news.


